» Articles » PMID: 36360466

Fighting Cancer Around the World: A Framework for Action

Abstract

Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe-and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle. A series of panels have been organized by the European Alliance for Personalised Medicine (EAPM) to identify different aspects of cancer care around the globe. There is significant diversity in key issues such as NGS, RWE, molecular diagnostics, and reimbursement in different regions. In all, it leads to disparities in access and diagnostics, patients' engagement, and efforts for a better understanding of cancer.

Citing Articles

Efficient and Accurate Brain Tumor Classification Using Hybrid MobileNetV2-Support Vector Machine for Magnetic Resonance Imaging Diagnostics in Neoplasms.

Adamu M, Kawuwa H, Qiang L, Nyatega C, Younis A, Fahad M Brain Sci. 2025; 14(12.

PMID: 39766377 PMC: 11674380. DOI: 10.3390/brainsci14121178.


Landscape of germline variants in breast and ovarian cancer in Peru.

Ferreyra Y, Rosas G, Cock-Rada A, Araujo J, Bravo L, Doimi F Front Oncol. 2023; 13:1227864.

PMID: 37664050 PMC: 10470619. DOI: 10.3389/fonc.2023.1227864.


Cancer patients' return-to-work adaptation experience and coping resources: a grounded theory study.

Xu J, Zhou Y, Li J, Tang J, Hu X, Chen Y BMC Nurs. 2023; 22(1):66.

PMID: 36899341 PMC: 9999662. DOI: 10.1186/s12912-023-01219-7.

References
1.
Horgan D, Curigliano G, Riess O, Hofman P, Buttner R, Conte P . Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. J Pers Med. 2022; 12(1). PMC: 8780351. DOI: 10.3390/jpm12010072. View

2.
Kamphuis B, Kanavos P . Assessing pricing and reimbursement policies for generic pharmaceuticals in the MENA region for improved efficiency, affordability and generic penetration. Health Policy Open. 2023; 2:100045. PMC: 10297517. DOI: 10.1016/j.hpopen.2021.100045. View

3.
Arafa M, Rabah D, Farhat K . Rising cancer rates in the Arab World: now is the time for action. East Mediterr Health J. 2020; 26(6):638-640. DOI: 10.26719/emhj.20.073. View

4.
Jedy-Agba E, Curado M, Ogunbiyi O, Oga E, Fabowale T, Igbinoba F . Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer Epidemiol. 2012; 36(5):e271-8. PMC: 3438369. DOI: 10.1016/j.canep.2012.04.007. View

5.
Landry L, Ali N, Williams D, Rehm H, Bonham V . Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice. Health Aff (Millwood). 2018; 37(5):780-785. DOI: 10.1377/hlthaff.2017.1595. View